Human SNP ID | rs13224682 |
---|---|
Human chromosome | chr7 |
Human SNP position | 107122773 |
Pig chromosome | chr9 |
Pig SNP position | 117768284 |
PubMed ID | 20195266 |
---|---|
Journal | Mol Psychiatry |
Link | www.ncbi.nlm.nih.gov/pubmed/20195266 |
Study | Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs. |
Disease/Trait | Response to antipsychotic treatment |
Initial sample | 421 European ancestry, 214 African American, and 103 cases |
Replication sample | NA |
Region | 7q22.3 |
Chromosome id | chr7 |
Chromosome position | 107122773 |
Reported gene | PRKAR2B |
Mapped gene | PRKAR2B |
Upstream gene id | |
Downstream gene id | |
SNP gene ids | 5577 |
Upstream gene distance | |
Downstream gene distance | |
SNP risk allele | rs13224682-? |
SNPs | rs13224682 |
Merged | 0 |
SNP id current | 13224682 |
Context | intron_variant |
Intergenic | 0 |
Allele frequency | 0.072 |
P value | 0.00000006 |
Pvalue mlog | 7.22184874961635 |
P value text | (clozapine-triglycerides) |
Or beta | |
%95 Ci | |
Platform | Affymetrix [492900] |
CNV | N |
Mapped trait | response to clozapine |
Mapped trait URI | http://purl.obolibrary.org/obo/GO_0097338 |
Study accession | GCST000618 |